|
HCFC1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.176920E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.349900E-02 |
| Normal-vs-Stage2 |
9.171200E-04 |
| Normal-vs-Stage3 |
1.604260E-04 |
| Normal-vs-Stage4 |
5.161400E-04 |
| Stage1-vs-Stage2 |
2.206100E-02 |
| Stage1-vs-Stage3 |
3.523500E-03 |
| Stage1-vs-Stage4 |
1.239520E-02 |
| Stage2-vs-Stage3 |
9.434000E-01 |
| Stage2-vs-Stage4 |
9.146600E-01 |
| Stage3-vs-Stage4 |
9.620600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.996230E-04 |
| Normal-vs-AfricanAmerican |
5.316600E-01 |
| Normal-vs-Asian |
2.410800E-01 |
| Caucasian-vs-AfricanAmerican |
3.964200E-02 |
| Caucasian-vs-Asian |
9.840300E-03 |
| AfricanAmerican-vs-Asian |
2.135400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.51609999999548E-05 |
| Normal-vs-Female |
1.002770E-01 |
| Male-vs-Female |
1.476600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.207500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.319860E-02 |
| Normal-vs-Age(61-80Yrs) |
1.099440E-03 |
| Normal-vs-Age(81-100Yrs) |
6.798200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.327200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.673800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.634810E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.419200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.008400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.240300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.073570E-01 |
| Normal-vs-Grade 2 |
8.642800E-03 |
| Normal-vs-Grade 3 |
3.400800E-04 |
| Normal-vs-Grade 4 |
1.041260E-03 |
| Grade 1-vs-Grade 2 |
3.038000E-03 |
| Grade 1-vs-Grade 3 |
5.419400E-04 |
| Grade 1-vs-Grade 4 |
6.839800E-04 |
| Grade 2-vs-Grade 3 |
1.538760E-01 |
| Grade 2-vs-Grade 4 |
1.499950E-01 |
| Grade 3-vs-Grade 4 |
6.834200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.144500E-03 |
| Normal-vs-ccB subtype |
4.976800E-03 |
| ccA subtype-vs-ccB subtype |
8.467800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.239500E-03 |
| Normal-vs-N1 |
4.495600E-01 |
| N0-vs-N1 |
4.769800E-01 |
|
|
